IQVIA Holdings Inc. (IQV)
- Previous Close
153.29 - Open
153.69 - Bid 145.00 x 800
- Ask 150.01 x 800
- Day's Range
148.74 - 154.99 - 52 Week Range
135.97 - 252.88 - Volume
1,382,523 - Avg. Volume
1,869,491 - Market Cap (intraday)
25.775B - Beta (5Y Monthly) 1.35
- PE Ratio (TTM)
20.33 - EPS (TTM)
7.33 - Earnings Date Jul 21, 2025 - Jul 25, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
197.72
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina.
www.iqvia.com89,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: IQV
View More
Performance Overview: IQV
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IQV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IQV
View MoreValuation Measures
Market Cap
25.78B
Enterprise Value
38.41B
Trailing P/E
20.33
Forward P/E
12.47
PEG Ratio (5yr expected)
0.91
Price/Sales (ttm)
1.75
Price/Book (mrq)
4.31
Enterprise Value/Revenue
2.48
Enterprise Value/EBITDA
11.18
Financial Highlights
Profitability and Income Statement
Profit Margin
8.61%
Return on Assets (ttm)
5.30%
Return on Equity (ttm)
21.64%
Revenue (ttm)
15.5B
Net Income Avi to Common (ttm)
1.33B
Diluted EPS (ttm)
7.33
Balance Sheet and Cash Flow
Total Cash (mrq)
1.88B
Total Debt/Equity (mrq)
242.91%
Levered Free Cash Flow (ttm)
2.16B
Research Analysis: IQV
View MoreResearch Reports: IQV
View MoreIQVIA Earnings: Near-Term Headwinds From Macro Issues; AI Investments Support Long-Term Growth
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
RatingPrice TargetMid Cap U.S. Pick List April 2025
This pick list highlights constituents of the Morningstar US Mid Cap Index that we believe offer investors the best risk-adjusted return prospects. The market capitalization range for U.S. mid-caps typically falls between $1 billion and $8 billion and represents 20% of the total capitalization of the U.S. equity market.
Iqvia Earnings: Solid Results Highlight Resilience of CRO Business; Positive Long-Term Outlook
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
RatingPrice TargetBUY on price pullbacks
IQVIA Holdings is the world's largest provider of biopharmaceutical development services and commercial outsourcing services. The company is the result of the 2016 merger of Quintiles Transnational, a contract research organization, and IMS Health, a healthcare data and analytics provider. IQVIA is headquartered in Research Triangle Park, North Carolina. IQVIA provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. IQVIA provides intelligent connections across all aspects of healthcare through its analytics, technology, big data resources, and extensive domain expertise. Its Connected Intelligence delivers actionable insights to enable customers to accelerate the clinical development and commercialization of new therapies. The company has about 86,000 employees. IQVIA has one of the largest collections of healthcare information in the world, which includes more than 1.2 billion comprehensive, longitudinal, non-identified patient records spanning sales and prescription data, medical claims, electronic medical records, genomics, and social media.
RatingPrice Target